SOLICITATION NOTICE
A -- Academic Institution in the city of Peru with a large trajectory of research in Leishmaniasis for
- Notice Date
- 2/7/2018
- Notice Type
- Synopsis
- NAICS
- 541715
— Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Contracting Office
- 693 Neiman Street FT Detrick MD 21702-9203
- ZIP Code
- 21702-9203
- Solicitation Number
- ADVFY18RD00013
- Response Due
- 2/23/2018
- Archive Date
- 3/8/2018
- Point of Contact
- Cheryl Vendemia, Phone 3016196004, - Thomas L. Hood, Contracting Officer, Phone 3016199236
- E-Mail Address
-
cheryl.r.vendemia.civ@mail.mil, thomas.l.hood26.civ@mail.mil
- Small Business Set-Aside
- N/A
- Description
- Notice of Intent to Sole Source The Naval Medical Logistics Command (NMLC) intends to award a sole source contract under the authority of FAR 6.302-1 (One source) to la Universidad Peruana Cayetano Heredia (UPCH) in Peru. NAMRU-6 is in need of an academic institution in the city of Lima, Peru with a large trajectory of research in Leishmaniasis, for a collaborative research effort to execute in Lima, Peru the study titled "Evaluation of a Diagnostic Device, CL Detect TM Rapid Test, for the Diagnosis of Cutaneous Leishmaniasis in Peru" (LRDD-PERU-02- NAMRU6.2015.0009). The primary objective of the study is to determine the sensitivity and specificity of the FDA-cleared CL Detect TM Rapid Test in Peru, using a test procedure that was modified from that described in the device instructions to optimize these parameters for the detection of Leishmania species identified in Peru. The CL Detect TM Rapid Test is the trade name for the Cutaneous Leishmaniasis Rapid Diagnostic Device (LRDD). This acquisition requires the research project to carry out coordination and obtainment of study authorization from local health facilities to perform the study in Peru; obtainment of local IRB approval; recruitment and training of personnel for performing the study; screening of at least 200 potential study participants; performing the informed consent process as described in the protocol; collecting study approved information and biological samples; labeling and keeping of samples in adequate cold-chain conditions; maintenance of all forms with identifiers in a locked office; preparation of biological samples for shipments to NAMRU-6 in adequate cold-chain conditions; shipment of samples to NAMRU-6; delivery to NAMRU-6 of all samples collected as part of the study, consent/assent documents, and all clinical report forms. All activities must be carried out with the utmost adherence to all ethical and quality control standards, in order to minimize risk of performance slips and maintain compliance with appropriation of funds and expectations of the sponsor. This institution is the only one with the required local approvals in place, the appropriate financial, human and technical resources, and experience and organizational controls needed to accomplish the study's goals. The period of performance is expected to be 12 months from the date of contract approval. NOTE: THIS NOTICE WAS NOT POSTED TO FEDBIZOPPS ON THE DATE INDICATED IN THE NOTICE ITSELF (07-FEB-2018); HOWEVER, IT DID APPEAR IN THE FEDBIZOPPS FTP FEED ON THIS DATE. PLEASE CONTACT 877-472-3779 or fbo.support@gsa.gov REGARDING THIS ISSUE.
- Web Link
-
Link To Document
(https://www.fbo.gov/spg/DON/BUMED/N62645/ADVFY18RD00013/listing.html)
- Place of Performance
- Address: Naval Medical Research Unit Six (NAMRU-6), Parasitology Department, Ave. Venezuela Cdra 36 s/n , Bellavista - Callao - Peru.
- Country: PE
- Country: PE
- Record
- SN04814878-F 20180209/180208101831 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |